Related Experiment Videos
Inflammatory-demyelinating polyneuropathies
1Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.
Neurologic Clinics
|August 1, 1992
Abstract:
Recent advances in the pathogenesis and management of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are presented. These diseases are both diagnosable and treatable. The role of Campylobacter infection preceding GBS and the use of intravenous immunoglobulin to treat CIDP are discussed.